Jason Bednar
Stock Analyst at Piper Sandler
(0.04)
# 2260
Out of 5,218 analysts
168
Total ratings
50.44%
Success rate
0.75%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NovoCure | Maintains: Overweight | 28 42 | 33.32 | 26.05% | 9 | Dec 13, 2024 | |
Patterson Cos | Maintains: Neutral | 26 24 | 31.05 | -22.71% | 8 | Dec 6, 2024 | |
KORU Medical Systems | Maintains: Overweight | 3 4 | 4.26 | -17.84% | 5 | Nov 14, 2024 | |
Solventum | Maintains: Neutral | 71 75 | 69.6 | 7.76% | 2 | Nov 8, 2024 | |
MDxHealth | Maintains: Overweight | 8 6 | 2.38 | 152.1% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 165 180 | 175.97 | 2.29% | 12 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 16 17 | 19.49 | -12.78% | 10 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 285 275 | 235.25 | 16.9% | 27 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 230 260 | 214.36 | 21.29% | 8 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 100 110 | 102.83 | 6.97% | 7 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 115 120 | 94.91 | 26.44% | 11 | Aug 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 7 7 | 3.06 | 128.76% | 5 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 4 1 | 0.47 | 112.77% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 14 12 | 6.08 | 97.37% | 10 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 86 86 | 76.59 | 12.29% | 6 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 13 | 13.15 | -1.14% | 1 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 35 32 | 19.75 | 62.03% | 7 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 310 372 | 539.38 | -31.03% | 4 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 14 9 | 2.19 | 310.96% | 2 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 305 280 | 225.62 | 24.1% | 6 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 200 80 | n/a | n/a | 6 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 2 1 | n/a | n/a | 6 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 7 2 | n/a | n/a | 5 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 95 | 80.98 | 17.31% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 130 142 | n/a | n/a | 2 | Jul 27, 2020 |